Tubidy

    CRSF 2024: Exciting Session | Knowledge Series for Genitourinary Cancers Day 1 with Dr. Ashwin

    01:16•10x

    If you find several Ads windows appear, just Close the Ads and return to this page, then click the "Download" button again, the Download process will start immediately!

    Sorry for showing a lot of ads, we need to make money to pay for the server and keep the tubidy service running smoothly. We apologize for the inconvenience, Your patience is greatly appreciated!

    Download Now

    Download Other Music/Videos

    You Might Also Like

    Expert Panel Discussion: Latest Insights in Lung Cancer Treatment | CRSF 2023 Review

    Expert Panel Discussion: Latest Insights in Lung Cancer Treatment | CRSF 2023 Review

    CRSF 7th Masterclass | 1st Line Therapy for MET Amplification & Exon 14 Mutation by Dr. Anmol Patel

    CRSF 7th Masterclass | 1st Line Therapy for MET Amplification & Exon 14 Mutation by Dr. Anmol Patel

    CRSF 7th Masterclass in Lung Cancer | Geriatric Oncology Workshop with Dr. Anupa Pillai

    CRSF 7th Masterclass in Lung Cancer | Geriatric Oncology Workshop with Dr. Anupa Pillai

    CRSF 2024: Exciting Session | Knowledge Series for Genitourinary Cancers Day 1 with Dr. Ashwin

    CRSF 2024: Exciting Session | Knowledge Series for Genitourinary Cancers Day 1 with Dr. Ashwin

    CRSF 7th Masterclass | 1st Line Therapy for ROS1 Rearrangement in NSCLC by Dr. Sandeep Jasuja

    CRSF 7th Masterclass | 1st Line Therapy for ROS1 Rearrangement in NSCLC by Dr. Sandeep Jasuja

    Dr Amol Dongre | FINAL OVERALL SURVIVAL FROM PROSPER

    Dr Amol Dongre | FINAL OVERALL SURVIVAL FROM PROSPER

    Dr Rajiv Kaushal | Gene fusion detection IHC vs FISH vs NGS | CRSF

    Dr Rajiv Kaushal | Gene fusion detection IHC vs FISH vs NGS | CRSF

    Management of Metastatic Urothelial Cancer with Dr. Aseem Samar | Oncology Perspective 2024

    Management of Metastatic Urothelial Cancer with Dr. Aseem Samar | Oncology Perspective 2024

    Radical Cystectomy vs Trimodality Therapy in Bladder Cancer: Propensity Score Analysis | CRSF 2024

    Radical Cystectomy vs Trimodality Therapy in Bladder Cancer: Propensity Score Analysis | CRSF 2024

    Sotorasib vs. Docetaxel in Previously Treated KRASG12C+ NSCLC | Dr. Randeep Singh | CRSF 2023

    Sotorasib vs. Docetaxel in Previously Treated KRASG12C+ NSCLC | Dr. Randeep Singh | CRSF 2023

    CRSF 7th Masterclass | Resistance to ROS1 Therapy & Post-Resistance Strategies by Dr. Abhishek Anand

    CRSF 7th Masterclass | Resistance to ROS1 Therapy & Post-Resistance Strategies by Dr. Abhishek Anand

    Dr Smriti Hari | A Multicentre prospective study to predict pathologic

    Dr Smriti Hari | A Multicentre prospective study to predict pathologic

    Dr Sudeep Das. LUNAR Study: Tumor Treating Field Therapy in Metastatic NSCLC | CRSF

    Dr Sudeep Das. LUNAR Study: Tumor Treating Field Therapy in Metastatic NSCLC | CRSF

    Panel Discussion Dr Tejinder Singh Choosing Right VAD In Lung Cancer Patients

    Panel Discussion Dr Tejinder Singh Choosing Right VAD In Lung Cancer Patients

    Panel Discussion | Pitfalls & Challenges of NGS Testing: Urban vs Rural | CRSF 07th Masterclass

    Panel Discussion | Pitfalls & Challenges of NGS Testing: Urban vs Rural | CRSF 07th Masterclass

    CRSF 7th Masterclass | First-Line RET Targeted Therapy in Lung Cancer by Dr. Chakor Vora

    CRSF 7th Masterclass | First-Line RET Targeted Therapy in Lung Cancer by Dr. Chakor Vora

    CRSF 07th Masterclass: 5-Year OS with Tecentriq in ES-SCLC | Panel Discussion with Experts

    CRSF 07th Masterclass: 5-Year OS with Tecentriq in ES-SCLC | Panel Discussion with Experts

    Dr Sabarinathan Radhakrishnan | Immunoproteasome expression in solid tumours | CRSF

    Dr Sabarinathan Radhakrishnan | Immunoproteasome expression in solid tumours | CRSF

    Phase 3 THOR Study Results: Erdafitinib vs. Chemotherapy in Advanced Urothelial Cancer | CRSF 2024

    Phase 3 THOR Study Results: Erdafitinib vs. Chemotherapy in Advanced Urothelial Cancer | CRSF 2024

    CRSF 7th Masterclass | First-Line Therapy for NTRK+ Lung Cancer by Dr. Bhavesh Poladia

    CRSF 7th Masterclass | First-Line Therapy for NTRK+ Lung Cancer by Dr. Bhavesh Poladia